Race Oncology Limited (RAC.AX)
AUD 1.33
(-3.64%)
AUD 1.33
(-3.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -9.54 Million | -10.65 Million | -6.25 Million | -4.69 Million | -2.46 Million | -2.67 Million |
| Net Income | -13.81 Million | -9.92 Million | -11.2 Million | -6.34 Million | -3.84 Million | -3.65 Million |
| Depreciation & Amortization | 281.19 Thousand | 281.19 Thousand | 281.19 Thousand | 281.19 Thousand | 281.19 Thousand | 281.19 Thousand |
| Deferred income taxes | - | -3.06 Million | -2.67 Million | -2.63 Million | -1.65 Million | -811.86 Thousand |
| Stock-based compensation | 1.43 Million | 590.5 Thousand | 3.07 Million | 2.27 Million | 1.09 Million | 812.04 Thousand |
| Change in working capital | 1.87 Million | -1.68 Million | 1.55 Million | -905.25 Thousand | 3649.00 | -181.00 |
| Other non-cash items | 681.37 Thousand | 3.14 Million | 2.71 Million | 2.62 Million | 1.65 Million | 704.2 Thousand |
| Investing Cash Flow | - | 7.9 Million | -1.00 | - | - | - |
| Investments in PPE | -1.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 5.2 Million | -1.28 Million | 30.51 Million | 12.27 Million | 3.2 Million | -33.84 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -4621.00 | -1.28 Million | -463.48 Thousand | -510.53 Thousand | -142.06 Thousand | -33.84 Thousand |
| Common Stock Issuance | 5.21 Million | -1.28 Million | 30.51 Million | 12.27 Million | 3.2 Million | -33.84 Thousand |
| Other Financing Activities | 5.2 Million | -1.28 Million | 30.51 Million | 510.53 Thousand | 142.06 Thousand | -33.84 Thousand |
| Accounts receivables | 1.59 Million | -1.64 Million | 65.7 Thousand | -79.25 Thousand | -48.3 Thousand | -181.00 |
| Accounts payables | 681.37 Thousand | -265.54 Thousand | 894.23 Thousand | 279.45 Thousand | 51.53 Thousand | -117.58 Thousand |
| Inventory | - | - | - | - | - | 121.09 Thousand |
| Other working capital | 281.47 Thousand | 225.5 Thousand | 592.93 Thousand | -1.1 Million | 421.00 | -3509.00 |
| Cash at beginning of period | 21.52 Million | 6.04 Million | 9.32 Million | 1.73 Million | 988.71 Thousand | 3.7 Million |
| Cash at end of period | 17.18 Million | 1.92 Million | 6.04 Million | 9.32 Million | 1.73 Million | 988.71 Thousand |
| Capital Expenditure | -1.00 | - | - | - | - | - |
| Effect of forex changes on cash | 5446.00 | -86.32 Thousand | -38.22 Thousand | 9394.00 | -4730.00 | -13.44 Thousand |
| Net cash flow / Change in cash | -4.33 Million | -4.12 Million | -3.28 Million | 7.59 Million | 742.05 Thousand | -2.72 Million |
| Free Cash Flow | -9.54 Million | -10.65 Million | -6.25 Million | -4.69 Million | -2.46 Million | -2.67 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.15 Million | -13.81 Million | -5.66 Million | -9.92 Million | -5.51 Million | -4.41 Million |
| Depreciation & Amortization | 140.59 Thousand | 281.19 Thousand | 140.59 Thousand | 281.19 Thousand | 140.59 Thousand | 140.59 Thousand |
| Deferred income taxes | - | - | - | -3.06 Million | 1.11 Million | - |
| Stock-based compensation | 1.14 Million | - | 284.31 Thousand | 590.5 Thousand | 250.36 Thousand | 340.13 Thousand |
| Change in working capital | 1.87 Million | 2.56 Million | - | -1.68 Million | -1.41 Million | - |
| Other non-cash items | 3.59 Million | -286.08 Thousand | -2.35 Million | 3.14 Million | 867.99 Thousand | -1.31 Million |
| Investing Cash Flow | - | - | 21.52 Million | 7.9 Million | -21.52 Million | 33.54 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 4.88 Million | 5.2 Million | 320.6 Thousand | -1.28 Million | 1.00 | -1.28 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -1.28 Million | 1.00 | -1.28 Million |
| Common Stock Issuance | 4.88 Million | 5.2 Million | 320.6 Thousand | -1.28 Million | - | - |
| Other Financing Activities | 4.88 Million | - | 320.6 Thousand | -1.28 Million | 1.00 | - |
| Accounts receivables | 1.59 Million | 1.59 Million | - | -1.64 Million | -1.64 Million | - |
| Accounts payables | - | 681.37 Thousand | - | -265.54 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 281.47 Thousand | 281.47 Thousand | - | 225.5 Thousand | 225.5 Thousand | - |
| Cash at beginning of period | 13.71 Million | 1.92 Million | 1.92 Million | 6.04 Million | 26.37 Million | 6.04 Million |
| Cash at end of period | 1.38 Million | 1.38 Million | 13.71 Million | 1.92 Million | 1.92 Million | 26.37 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -23.63 Thousand | - | 29.08 Thousand | -86.32 Thousand | -68.93 Thousand | -17.38 Thousand |
| Net cash flow / Change in cash | -12.32 Million | -531.54 Thousand | 11.79 Million | -4.12 Million | -24.45 Million | 20.33 Million |
| Free Cash Flow | -1.39 Million | -9.54 Million | -8.15 Million | -10.65 Million | -4.78 Million | -5.86 Million |
VICO
MND
3386
MFH
XCOP
090350